K. Anders's most recent trade in Twin Hospitality Group Inc. - Ordinary Shares - Class A was a trade of 100,000 Restricted Stock Units done . Disclosure was reported to the exchange on June 24, 2025.
| Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
|---|---|---|---|---|---|---|---|---|---|---|
| Twin Hospitality Group Inc... | Kenneth J. Anderson | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 24 Jun 2025 | 100,000 | 100,000 | - | - | Restricted Stock Units | |
| C4 Therapeutics Inc | Kenneth C. Anderson | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 18 Jun 2025 | 35,500 | 35,500 | - | - | Stock Option (Right to Buy) | |
| Asana Inc - Ordinary Share... | Krista Anderson-Copperman | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 16 Jun 2025 | 13,089 | 62,710 | - | 0 | Class A Common Stock | |
| Abercrombie & Fitch Co. - ... | Kerrii B. Anderson | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 11 Jun 2025 | 2,089 | 2,869 | - | - | Restricted Stock Unit | |
| Abercrombie & Fitch Co. - ... | Kerrii B. Anderson | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 11 Jun 2025 | 780 | 2,089 | - | - | Restricted Stock Unit | |
| Abercrombie & Fitch Co. - ... | Kerrii B. Anderson | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 11 Jun 2025 | 780 | 41,450 (0%) | 0% | 0 | Class A Common Stock | |
| Laboratory Corp. Of Americ... | Kerrii B. Anderson | Director | Sale of securities on an exchange or to another person at price $ 260.00 per share. | 11 Jun 2025 | 500 | 12,666 (0%) | 0% | 260 | 130,000 | Common Stock |
| Booz Allen Hamilton Holdin... | Kristine Martin Anderson | EVP & Chief Operating Officer | Payment of exercise price or tax liability using portion of securities received from the company at price $ 106.25 per share. | 01 Jun 2025 | 4,482 | 88,996 (0%) | 0% | 106.3 | 476,213 | Class A Common Stock |
| Marsh & McLennan Cos., Inc. | Anthony K. Anderson | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 01 Jun 2025 | 929 | 15,420 | - | - | Restricted Stk. Units-Dir. Stk. Plan | |
| Adial Pharmaceuticals Inc | J. Kermit Anderson | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 29 May 2025 | 28,000 | 28,000 | - | - | Stock Option (Right to Buy) | |
| Twin Hospitality Group Inc... | Kenneth J. Anderson | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 27 May 2025 | 10,000 | 10,000 | - | - | Stock option (right to buy) | |
| Booz Allen Hamilton Holdin... | Kristine Martin Anderson | EVP & Chief Operating Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 27 May 2025 | 7,286 | 93,478 (0%) | 0% | 0 | Class A Common Stock | |
| Booz Allen Hamilton Holdin... | Kristine Martin Anderson | EVP & Chief Operating Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 20 May 2025 | 12,020 | 91,998 (0%) | 0% | 0 | Class A Common Stock | |
| Booz Allen Hamilton Holdin... | Kristine Martin Anderson | EVP & Chief Operating Officer | Payment of exercise price or tax liability using portion of securities received from the company at price $ 129.69 per share. | 20 May 2025 | 5,806 | 86,192 (0%) | 0% | 129.7 | 752,980 | Class A Common Stock |
| Marsh & McLennan Cos., Inc. | Anthony K. Anderson | Director | Other type of transaction at price $ 0.00 per share. | 15 May 2025 | 52 | 14,491 | - | - | Restricted Stk. Units-Dir. Stk. Plan | |
| CNB Financial Corp (PA) | Anna K. Andersen | SVP & Chief Risk Officer, Individual | Grant, award, or other acquisition of securities at price $ 22.83 per share. | 14 May 2025 | 1,482 | 3,028 (0%) | 0% | 22.8 | 33,834 | Common Stock |
| TOMI Environmental Solutio... | Kelly J. Anderson | Director | Grant, award, or other acquisition of securities at price $ 0.85 per share. | 12 May 2025 | 20,000 | 130,375 | - | 0.9 | 17,000 | Common Stock |
| Abercrombie & Fitch Co. - ... | Kerrii B. Anderson | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 05 May 2025 | 128 | 3,183 | - | - | Phantom Stock | |
| Asana Inc - Ordinary Share... | Anderson-Copperman Krista | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 01 May 2025 | 805 | 49,621 | - | 0 | Class A Common Stock | |
| Sherwin-Williams Co. | Kerrii B. Anderson | Director | Grant, award, or other acquisition of securities at price $ 344.79 per share. | 04 Apr 2025 | 29 | 917 (0%) | 0% | 344.8 | 9,999 | Common Stock |
| C4 Therapeutics Inc | Kenneth C. Anderson | Director | Grant, award, or other acquisition of securities at price $ 1.44 per share. | 01 Apr 2025 | 7,841 | 127,609 | - | 1.4 | 11,252 | Common Stock |
| Booz Allen Hamilton Holdin... | Kristine Martin Anderson | EVP & Chief Operating Officer | Payment of exercise price or tax liability using portion of securities received from the company at price $ 104.58 per share. | 31 Mar 2025 | 3,399 | 79,978 (0%) | 0% | 104.6 | 355,467 | Class A Common Stock |
| Vertiv Holdings Co - Ordin... | Anders Karlborg | EVP, Man., Logistics and Op Ex | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 27 Mar 2025 | 2 | 21,675 (0%) | 0% | 0 | Class A Common Stock | |
| Vertiv Holdings Co - Ordin... | Anders Karlborg | EVP, Man., Logistics and Op Ex | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 07 Mar 2025 | 19,938 | 19,938 | - | - | Stock Options | |
| Laboratory Corp. Of Americ... | Kerrii B. Anderson | Director | Sale of securities on an exchange or to another person at price $ 255.63 per share. | 05 Mar 2025 | 500 | 13,166 (0%) | 0% | 255.6 | 127,817 | Common Stock |
| Vertiv Holdings Co - Ordin... | Anders Karlborg | EVP, Man., Logistics and Op Ex | Payment of exercise price or tax liability using portion of securities received from the company at price $ 85.41 per share. | 03 Mar 2025 | 831 | 21,673 (0%) | 0% | 85.4 | 70,976 | Class A Common Stock |
| Columbia Banking System, Inc. | Drew K. Anderson | Chief Administrative Officer | Payment of exercise price or tax liability using portion of securities received from the company at price $ 26.73 per share. | 28 Feb 2025 | 1,944 | 23,342 (0%) | 0% | 26.7 | 51,963 | Common Stock |
| Columbia Banking System, Inc. | Drew K. Anderson | Chief Administrative Officer | Payment of exercise price or tax liability using portion of securities received from the company at price $ 26.73 per share. | 28 Feb 2025 | 1,127 | 25,286 (0%) | 0% | 26.7 | 30,125 | Common Stock |
| Columbia Banking System, Inc. | Drew K. Anderson | Chief Administrative Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 25 Feb 2025 | 37,593 | 37,593 | - | - | Restricted Stock Unit | |
| Columbia Banking System, Inc. | Drew K. Anderson | Chief Administrative Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 25 Feb 2025 | 7,518 | 45,111 | - | - | Restricted Stock Unit | |
| Columbia Banking System, Inc. | Drew K. Anderson | Chief Administrative Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 25 Feb 2025 | 3,759 | 18,708 | - | - | Performance Restricted Stock Unit | |
| Columbia Banking System, Inc. | Drew K. Anderson | Chief Administrative Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 25 Feb 2025 | 3,759 | 14,949 | - | - | Performance Restricted Stock Unit | |
| Sherwin-Williams Co. | Kerrii B. Anderson | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 18 Feb 2025 | 517 | 5,261 (0%) | 0% | 0 | Common Stock | |
| Columbia Banking System, Inc. | Drew K. Anderson | Chief Administrative Officer | Payment of exercise price or tax liability using portion of securities received from the company at price $ 27.41 per share. | 14 Feb 2025 | 884 | 26,413 (0%) | 0% | 27.4 | 24,230 | Common Stock |
| Marsh & McLennan Cos., Inc. | Anthony K. Anderson | Director | Other type of transaction at price $ 0.00 per share. | 14 Feb 2025 | 50 | 14,438 | - | - | Restricted Stk. Units-Dir. Stk. Plan | |
| Laboratory Corp. Of Americ... | Kerrii B. Anderson | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 11 Feb 2025 | 897 | 897 | - | - | Restricted Stock Unit | |
| Centessa Pharmaceuticals p... | Karen Anderson | Chief People Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 07 Feb 2025 | 30,526 | 244,464 | - | - | Share Option (right to buy) | |
| Centessa Pharmaceuticals p... | Karen Anderson | Chief People Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 4.01 per share. | 07 Feb 2025 | 30,526 | 84,848 | - | 4.0 | 122,409 | Ordinary Shares |
| Centessa Pharmaceuticals p... | Karen Anderson | Chief People Officer | Sale of securities on an exchange or to another person at price $ 19.03 per share. | 07 Feb 2025 | 30,526 | 54,322 | - | 19.0 | 580,797 | Ordinary Shares |
| Centessa Pharmaceuticals p... | Karen Anderson | Chief People Officer | Sale of securities on an exchange or to another person at price $ 18.99 per share. | 07 Feb 2025 | 429 | 54,322 | - | 19.0 | 8,147 | Ordinary Shares |
| Centessa Pharmaceuticals p... | Karen Anderson | Chief People Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 07 Feb 2025 | 429 | 244,035 | - | - | Share Option (right to buy) | |
| Centessa Pharmaceuticals p... | Karen Anderson | Chief People Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 4.01 per share. | 07 Feb 2025 | 429 | 54,751 | - | 4.0 | 1,720 | Ordinary Shares |
| Laboratory Corp. Of Americ... | Kerrii B. Anderson | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 06 Feb 2025 | 944 | 0 | - | - | Restricted Stock Unit | |
| Laboratory Corp. Of Americ... | Kerrii B. Anderson | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 06 Feb 2025 | 944 | 13,666 (0%) | 0% | - | Common Stock | |
| Asana Inc - Ordinary Share... | Krista Anderson-Copperman | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 03 Feb 2025 | 609 | 48,816 | - | 0 | Class A Common Stock | |
| Centessa Pharmaceuticals p... | Karen Anderson | Chief People Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 01 Feb 2025 | 120,000 | 120,000 | - | - | Share Option (right to buy) | |
| Centessa Pharmaceuticals p... | Karen Anderson | Chief People Officer | Payment of exercise price or tax liability using portion of securities received from the company at price $ 16.92 per share. | 01 Feb 2025 | 10,732 | 60,793 | - | 16.9 | 181,585 | Ordinary Shares |
| Centessa Pharmaceuticals p... | Karen Anderson | Chief People Officer | Sale of securities on an exchange or to another person at price $ 16.86 per share. | 01 Feb 2025 | 6,471 | 54,322 | - | 16.9 | 109,124 | Ordinary Shares |
| Summit Materials Inc - Ord... | Karli S. Anderson | See Remarks | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 15 Jan 2025 | 15,289 | 15,289 | - | - | Restricted Stock Units | |
| Summit Materials Inc - Ord... | Karli S. Anderson | See Remarks | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 15 Jan 2025 | 7,587 | 50,603 (0%) | 0% | 0 | Class A Common Stock | |
| Summit Materials Inc - Ord... | Karli S. Anderson | See Remarks | Payment of exercise price or tax liability using portion of securities received from the company at price $ 52.19 per share. | 15 Jan 2025 | 2,318 | 48,285 (0%) | 0% | 52.2 | 120,976 | Class A Common Stock |
| Laboratory Corp. Of Americ... | Kerrii B. Anderson | Director | Sale of securities on an exchange or to another person at price $ 235.00 per share. | 07 Jan 2025 | 1,000 | 12,722 (0%) | 0% | 235 | 235,000 | Common Stock |
| Mullen Automotive Inc | John Kevin Andersen | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 03 Jan 2025 | 175,000 | 175,163 | - | 0 | Common Stock | |
| Sherwin-Williams Co. | Kerrii B. Anderson | Director | Grant, award, or other acquisition of securities at price $ 344.83 per share. | 03 Jan 2025 | 29 | 886 (0%) | 0% | 344.8 | 10,000 | Common Stock |
| C4 Therapeutics Inc | Kenneth C. Anderson | Director | Grant, award, or other acquisition of securities at price $ 3.66 per share. | 02 Jan 2025 | 3,074 | 119,768 | - | 3.7 | 11,251 | Common Stock |
| Summit Materials Inc - Ord... | Karli S. Anderson | See Remarks | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 20 Dec 2024 | 13,589 | 52,706 (0%) | 0% | - | Class A Common Stock | |
| Summit Materials Inc - Ord... | S. Karli Anderson | See Remarks | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 20 Dec 2024 | 13,589 | 0 | - | - | Restricted Stock Units | |
| Summit Materials Inc - Ord... | Anderson Karli S. | See Remarks | Payment of exercise price or tax liability using portion of securities received from the company at price $ 50.50 per share. | 20 Dec 2024 | 9,690 | 43,016 (0%) | 0% | 50.5 | 489,345 | Class A Common Stock |
| Summit Materials Inc - Ord... | Anderson S. Karli | See Remarks | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 20 Dec 2024 | 6,148 | 39,117 (0%) | 0% | - | Class A Common Stock | |
| Summit Materials Inc - Ord... | Karli Anderson S. | See Remarks | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 20 Dec 2024 | 6,148 | 0 | - | - | Restricted Stock Units | |
| Summit Materials Inc - Ord... | Anderson Karli S. | See Remarks | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 20 Dec 2024 | 2,409 | 32,969 (0%) | 0% | - | Class A Common Stock | |
| Summit Materials Inc - Ord... | Karli Anderson S. | See Remarks | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 20 Dec 2024 | 2,409 | 0 | - | - | Restricted Stock Units | |
| Vertiv Holdings Co - Ordin... | Anders Karlborg | EVP, Man., Logistics and Op Ex | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 19 Dec 2024 | 2 | 22,504 (0%) | 0% | 0 | Class A Common Stock | |
| Centessa Pharmaceuticals p... | Karen Anderson | Chief People Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 13 Dec 2024 | 10,624 | 43,510 | - | - | Share Option (right to buy) | |
| Centessa Pharmaceuticals p... | Karen Anderson | Chief People Officer | Sale of securities on an exchange or to another person at price $ 17.32 per share. | 13 Dec 2024 | 10,624 | 71,525 | - | 17.3 | 184,036 | Ordinary Shares |
| Centessa Pharmaceuticals p... | Karen Anderson | Chief People Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 3.85 per share. | 13 Dec 2024 | 10,624 | 82,149 | - | 3.8 | 40,902 | Ordinary Shares |
| Centessa Pharmaceuticals p... | Karen Anderson | Chief People Officer | Sale of securities on an exchange or to another person at price $ 17.01 per share. | 13 Dec 2024 | 5,876 | 71,525 | - | 17.0 | 99,974 | Ordinary Shares |
| Centessa Pharmaceuticals p... | Karen Anderson | Chief People Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 13 Dec 2024 | 5,876 | 54,134 | - | - | Share Option (right to buy) | |
| Centessa Pharmaceuticals p... | Karen Anderson | Chief People Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 3.85 per share. | 13 Dec 2024 | 5,876 | 77,401 | - | 3.9 | 22,623 | Ordinary Shares |
| Abercrombie & Fitch Co. - ... | B. Kerrii Anderson | Director | Gift of securities by or to the insider at price $ 0.00 per share. | 03 Dec 2024 | 2,000 | 40,670 (0%) | 0% | 0 | Class A Common Stock | |
| Vertiv Holdings Co - Ordin... | Anders Karlborg | EVP, Man., Logistics and Op Ex | Sale of securities on an exchange or to another person at price $ 128.98 per share. | 02 Dec 2024 | 39,339 | 22,501 (0%) | 0% | 129.0 | 5,073,944 | Class A Common Stock |
| Vertiv Holdings Co - Ordin... | Anders Karlborg | EVP, Man., Logistics and Op Ex | Exercise or conversion of derivative security received from the company (such as an option) at price $ 11.25 per share. | 02 Dec 2024 | 19,646 | 51,713 (0%) | 0% | 11.3 | 221,018 | Class A Common Stock |
| Vertiv Holdings Co - Ordin... | Anders Karlborg | EVP, Man., Logistics and Op Ex | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 02 Dec 2024 | 19,646 | 19,646 | - | - | Stock Options | |
| Vertiv Holdings Co - Ordin... | Anders Karlborg | EVP, Man., Logistics and Op Ex | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 02 Dec 2024 | 9,566 | 9,567 | - | - | Stock Options | |
| Vertiv Holdings Co - Ordin... | Anders Karlborg | EVP, Man., Logistics and Op Ex | Exercise or conversion of derivative security received from the company (such as an option) at price $ 14.49 per share. | 02 Dec 2024 | 9,566 | 32,067 (0%) | 0% | 14.5 | 138,611 | Class A Common Stock |
| Vertiv Holdings Co - Ordin... | Anders Karlborg | EVP, Man., Logistics and Op Ex | Exercise or conversion of derivative security received from the company (such as an option) at price $ 15.84 per share. | 02 Dec 2024 | 6,080 | 57,793 (0%) | 0% | 15.8 | 96,307 | Class A Common Stock |
| Vertiv Holdings Co - Ordin... | Anders Karlborg | EVP, Man., Logistics and Op Ex | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 02 Dec 2024 | 6,080 | 18,240 | - | - | Stock Options | |
| Vertiv Holdings Co - Ordin... | Anders Karlborg | EVP, Man., Logistics and Op Ex | Exercise or conversion of derivative security received from the company (such as an option) at price $ 24.87 per share. | 02 Dec 2024 | 4,047 | 61,840 (0%) | 0% | 24.9 | 100,649 | Class A Common Stock |
| Vertiv Holdings Co - Ordin... | Anders Karlborg | EVP, Man., Logistics and Op Ex | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 02 Dec 2024 | 4,047 | 12,143 | - | - | Stock Options | |
| Marsh & McLennan Cos., Inc. | Anthony K. Anderson | Director | Other type of transaction at price $ 0.00 per share. | 15 Nov 2024 | 52 | 14,387 | - | - | Restricted Stk. Units-Dir. Stk. Plan | |
| Asana Inc - Ordinary Share... | Krista Anderson-Copperman | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 01 Nov 2024 | 1,088 | 48,207 | - | 0 | Class A Common Stock | |
| Laboratory Corp. Of Americ... | Kerrii B. Anderson | Director | Sale of securities on an exchange or to another person at price $ 230.00 per share. | 24 Oct 2024 | 1,000 | 13,722 (0%) | 0% | 230 | 230,000 | Common Stock |
| Sherwin-Williams Co. | Kerrii B. Anderson | Director | Grant, award, or other acquisition of securities at price $ 384.65 per share. | 04 Oct 2024 | 26 | 854 (0%) | 0% | 384.7 | 10,001 | Common Stock |
| C4 Therapeutics Inc | Kenneth C. Anderson | Director | Grant, award, or other acquisition of securities at price $ 5.56 per share. | 01 Oct 2024 | 2,023 | 116,694 | - | 5.6 | 11,248 | Common Stock |
| Worthington Industries, Inc. | Kerrii B. Anderson | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 27 Sep 2024 | 563 | 12,040 | - | - | Phantom Stock | |
| Worthington Industries, Inc. | Kerrii B. Anderson | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 26 Sep 2024 | 3,300 | 71,334 (0%) | 0% | 0 | Common Shares | |
| Vertiv Holdings Co - Ordin... | Anders Karlborg | EVP, Man., Logistics and Op Ex | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 26 Sep 2024 | 2 | 22,501 (0%) | 0% | 0 | Class A Common Stock | |
| Marsh & McLennan Cos., Inc. | Anthony K. Anderson | Director | Other type of transaction at price $ 0.00 per share. | 15 Aug 2024 | 53 | 14,335 | - | - | Restricted Stk. Units-Dir. Stk. Plan | |
| Skyline Champion Corp | Keith A. Anderson | Director | Sale of securities on an exchange or to another person at price $ 83.44 per share. | 09 Aug 2024 | 23,465 | 210,529 (0%) | 0% | 83.4 | 1,957,920 | Common Stock |
| Skyline Champion Corp | Keith A. Anderson | Director | Sale of securities on an exchange or to another person at price $ 83.91 per share. | 09 Aug 2024 | 5,330 | 233,994 (0%) | 0% | 83.9 | 447,240 | Common Stock |
| Tharimmune Inc | Kelly J. Anderson | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 09 Aug 2024 | 2,353 | 52,353 | - | - | Options (right to buy) | |
| Skyline Champion Corp | Keith A. Anderson | Director | Sale of securities on an exchange or to another person at price $ 83.65 per share. | 09 Aug 2024 | 1,205 | 209,324 (0%) | 0% | 83.6 | 100,798 | Common Stock |
| Laboratory Corp. Of Americ... | Kerrii B. Anderson | Director | Sale of securities on an exchange or to another person at price $ 225.00 per share. | 07 Aug 2024 | 586 | 14,722 (0%) | 0% | 225 | 131,850 | Common Stock |
| Laboratory Corp. Of Americ... | Kerrii B. Anderson | Director | Sale of securities on an exchange or to another person at price $ 225.00 per share. | 07 Aug 2024 | 414 | 15,308 (0%) | 0% | 225 | 93,150 | Common Stock |
| Skyline Champion Corp | Keith A. Anderson | Director | Grant, award, or other acquisition of securities at price $ 81.51 per share. | 01 Aug 2024 | 1,226 | 239,324 (0%) | 0% | 81.5 | 99,931 | Common Stock |
| Asana Inc - Ordinary Share... | Krista Anderson-Copperman | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 01 Aug 2024 | 893 | 47,119 | - | 0 | Class A Common Stock | |
| Sherwin-Williams Co. | Kerrii B. Anderson | Director | Grant, award, or other acquisition of securities at price $ 303.03 per share. | 05 Jul 2024 | 33 | 826 (0%) | 0% | 303.0 | 10,000 | Common Stock |
| C4 Therapeutics Inc | Kenneth C. Anderson | Director | Grant, award, or other acquisition of securities at price $ 4.85 per share. | 01 Jul 2024 | 2,320 | 114,671 | - | 4.9 | 11,252 | Common Stock |
| Vertiv Holdings Co - Ordin... | Anders Karlborg | EVP, Man., Logistics and Op Ex | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 26 Jun 2024 | 2 | 22,499 (0%) | 0% | 0 | Class A Common Stock | |
| Columbia Banking System, Inc. | Drew K. Anderson | Chief Administrative Officer | Payment of exercise price or tax liability using portion of securities received from the company at price $ 18.43 per share. | 21 Jun 2024 | 576 | 27,297 (0%) | 0% | 18.4 | 10,616 | Common Stock |
| C4 Therapeutics Inc | Kenneth C. Anderson | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 20 Jun 2024 | 32,500 | 32,500 | - | - | Stock Option (Right to Buy) |